Is a complete VVOS research report available?

No complete published report is available for Vivos Therapeutics, Inc. (VVOS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Vivos Therapeutics, Inc. (VVOS)

NASDAQ: VVOS · USD

$0.12

-0.01 (-3.9%)· Recorded snapshot

Market cap	2.5M
Revenue (ttm)	20.9M
Net income (ttm)	-25.5M
EPS (ttm)	-$1.83
Shares out	20.1M
Volume	812,807
Beta	6.07

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 20.9M
Net income (ttm): -25.5M
EPS (ttm): -$1.83
Market cap: 2.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Metric	Value
Amount currency	USD
CIK code	0001716166
Company name	Vivos Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	92859E207
Earnings date	2026-11-18
Earnings time	amc
Employees	270
Employees change	2
Employees growth	0.75%
Enterprise value	$13.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2016
Industry	Medical Devices
IPO date	2020-12-11
Is primary listing	Yes
Is SPAC	No
ISIN number	US92859E2072
Last 10-K release date	2026-04-15
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2023-10-27
Last stock split type	Reverse
Market cap	$2.5M
Market cap category	Nano-Cap
Next earnings date	2026-11-18
Options	No
Price	$0.12
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	VVOS
U.S. state	Colorado
Website	https://www.vivos.com

Metric

Value

Amount currency

USD

CIK code

0001716166

Company name

Vivos Therapeutics, Inc.

Country

United States

Country code

CUSIP number

92859E207

Earnings date

2026-11-18

Earnings time

amc

Employees

270

Employees change

Employees growth

0.75%

Enterprise value

$13.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2016

Industry

Medical Devices

IPO date

2020-12-11

Is primary listing

Yes

Is SPAC

ISIN number

US92859E2072

Last 10-K release date

2026-04-15

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split date

2023-10-27

Last stock split type

Reverse

Market cap

$2.5M

Market cap category

Nano-Cap

Next earnings date

2026-11-18

Options

Price

$0.12

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

VVOS

U.S. state

Colorado

Website

https://www.vivos.com

Metric	Value
Earnings yield	-1,481.48%
EV/Sales	0.64x
FCF / EV yield	-142.82%
FCF yield	-736.61%
Forward EV/Sales	0.58x
Forward P/S	0.11x
Industry forward P/E	19.81x
Industry P/E	39.28x
P/S ratio	0.12x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-1,481.48%

EV/Sales

0.64x

FCF / EV yield

-142.82%

FCF yield

-736.61%

Forward EV/Sales

0.58x

Forward P/S

0.11x

Industry forward P/E

19.81x

Industry P/E

39.28x

P/S ratio

0.12x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-107.9%
EBITDA margin	-99.33%
Gross margin	61.9%
Operating margin	-107.9%
Pretax margin	-122.61%
Profit margin	-121.79%
Profit per employee	$-94,281
Revenue per employee	$77,415
ROA	-56.19%
ROA (5Y)	-62.17%
ROCE	-600.64%
ROE	-8,585.26%
ROE (5Y)	-340%
ROIC	-114.22%
SBC / revenue	4.25%

Metric

Value

EBIT margin

-107.9%

EBITDA margin

-99.33%

Gross margin

61.9%

Operating margin

-107.9%

Pretax margin

-122.61%

Profit margin

-121.79%

Profit per employee

$-94,281

Revenue per employee

$77,415

ROA

-56.19%

ROA (5Y)

-62.17%

ROCE

-600.64%

ROE

-8,585.26%

ROE (5Y)

-340%

ROIC

-114.22%

SBC / revenue

4.25%

Metric	Value
EPS growth quarters	1
EPS growth years	3
Gross profit growth	60.78%
Gross profit growth (Q)	39.95%
Gross profit growth 3Y	11.57%
Gross profit growth 5Y	2.23%
Net income growth years	0
Revenue growth	45.22%
Revenue growth (Q)	34.9%
Revenue growth (QoQ)	0.23%
Revenue growth 3Y	10.6%
Revenue growth 5Y	7.52%
Revenue growth quarters	4
Revenue growth years	2

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

60.78%

Gross profit growth (Q)

39.95%

Gross profit growth 3Y

11.57%

Gross profit growth 5Y

2.23%

Net income growth years

Revenue growth

45.22%

Revenue growth (Q)

34.9%

Revenue growth (QoQ)

0.23%

Revenue growth 3Y

10.6%

Revenue growth 5Y

7.52%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-1.9M
Depreciation and amortization	$1.8M
EBIT	$-22.6M
EBITDA	$-20.8M
EPS	$-1.83
FCF per share	$-0.95
Financing cash flow	$16.4M
Free cash flow	$-19M
Free cash flow minus SBC	$-19.9M
Gross profit	$12.9M
Investing cash flow	$-1.9M
Net borrowing	$2.8M
Net cash flow	$-2.6M
Net income	$-25.5M
Operating cash flow minus SBC	$-18M
Operating income	$-22.6M
Revenue	$20.9M
Stock-based compensation	$889,000

Metric

Value

Capital expenditures

$-1.9M

Depreciation and amortization

$1.8M

EBIT

$-22.6M

EBITDA

$-20.8M

EPS

$-1.83

FCF per share

$-0.95

Financing cash flow

$16.4M

Free cash flow

$-19M

Free cash flow minus SBC

$-19.9M

Gross profit

$12.9M

Investing cash flow

$-1.9M

Net borrowing

$2.8M

Net cash flow

$-2.6M

Net income

$-25.5M

Operating cash flow minus SBC

$-18M

Operating income

$-22.6M

Revenue

$20.9M

Stock-based compensation

$889,000

Metric	Value
Altman Z-Score	-10.65
Book value per share	$-0.34
Goodwill	$8.6M
Interest coverage	-10.25
Long-term assets	$19.9M
Long-term liabilities	$7.7M
Net cash (debt)	$-10.7M
Net cash / market cap	-415.75%
Piotroski F-Score	4
Property, plant and equipment	$7.4M
Shareholders' equity	$-4M
Tangible book value	$-17.1M
Tangible book value per share	$-1.18
Total assets	$24.1M
Total cash	$1.8M
Total debt	$12.5M
Total liabilities	$28.1M
WACC	17.96%

Metric

Value

Altman Z-Score

-10.65

Book value per share

$-0.34

Goodwill

$8.6M

Interest coverage

-10.25

Long-term assets

$19.9M

Long-term liabilities

$7.7M

Net cash (debt)

$-10.7M

Net cash / market cap

-415.75%

Piotroski F-Score

Property, plant and equipment

$7.4M

Shareholders' equity

$-4M

Tangible book value

$-17.1M

Tangible book value per share

$-1.18

Total assets

$24.1M

Total cash

$1.8M

Total debt

$12.5M

Total liabilities

$28.1M

WACC

17.96%

Metric	Value
Asset turnover	0.83
Current assets	$4.2M
Current liabilities	$20.4M
Current ratio	0.21
Net working capital	$-9.3M
Quick ratio	0.16
Working capital	$-16.2M
Working capital turnover	-2.63

Metric

Value

Asset turnover

0.83

Current assets

$4.2M

Current liabilities

$20.4M

Current ratio

0.21

Net working capital

$-9.3M

Quick ratio

0.16

Working capital

$-16.2M

Working capital turnover

-2.63

Metric	Value
Buyback yield / dilution	-72.97%
Dividend yield	0%
Shareholder yield	-72.97%

Metric

Value

Buyback yield / dilution

-72.97%

Dividend yield

Shareholder yield

-72.97%

Metric	Value
150-day SMA	$0.50
1D price change	-3.9%
1M price change	-11.05%
1M total return	-11.05%
1W price change	-10.99%
1W total return	-10.99%
1Y price change	-95.4%
1Y return CAGR	-95.41%
1Y total return	-95.4%
20-day SMA	$0.14
200-day SMA	$0.76
3M price change	-68.95%
3M total return	-68.95%
3Y price change	-97.1%
3Y return CAGR	-69.28%
3Y total return	-97.1%
50-day SMA	$0.17
50-day SMA vs 200-day SMA	50under200
52-week high	$2.88
52-week high date	2025-10-29
52-week low	$0.12
52-week low date	2026-10-28
5Y price change	-99.86%
5Y return CAGR	-73.07%
5Y total return	-99.86%
6M price change	-85.5%
6M total return	-85.5%
All-time high	$360.25
All-time high date	2020-12-11
All-time low	$0.12
All-time low date	2026-10-28
Average true range (ATR)	$0.01
Average volume	8.2M
Beta (1Y)	-1.12
Beta (2Y)	0.47
Beta (5Y)	6.07
Change from 52-week high	-95.72%
Change from 52-week low	4.23%
Change from all-time high	-99.97%
Change from all-time low	5.79%
Change from open	1.31%
Day's gap	-5.14%
Dollar volume	$100,219
High price	$0.12
Low price	$0.12
Monthly RSI	35.97
Open price	$0.12
Position in 52-week range	94.29%
Premarket change	-4.36%
Premarket close	$0.13
Premarket price	$0.12
Premarket volume	24.1K
Previous close	$0.13
Price vs 150-day SMA	-75.05%
Price vs 20-day SMA	-10.99%
Price vs 200-day SMA	-83.58%
Price vs 50-day SMA	-27.11%
Relative volume	0.1
Return from IPO open	-99.93%
Return from IPO price	-97.86%
RSI	32.31
Sharpe ratio	-2.78
Sharpe ratio (3Y)	0.26
Sharpe ratio (5Y)	0.17
Sortino ratio	-3.46
Sortino ratio (3Y)	1.65
Sortino ratio (5Y)	0.9
Volume	812.8K
Weekly RSI	23.54
YTD price change	-93.83%
YTD total return	-93.83%

Metric

Value

150-day SMA

$0.50

1D price change

-3.9%

1M price change

-11.05%

1M total return

-11.05%

1W price change

-10.99%

1W total return

-10.99%

1Y price change

-95.4%

1Y return CAGR

-95.41%

1Y total return

-95.4%

20-day SMA

$0.14

200-day SMA

$0.76

3M price change

-68.95%

3M total return

-68.95%

3Y price change

-97.1%

3Y return CAGR

-69.28%

3Y total return

-97.1%

50-day SMA

$0.17

50-day SMA vs 200-day SMA

50under200

52-week high

$2.88

52-week high date

2025-10-29

52-week low

$0.12

52-week low date

2026-10-28

5Y price change

-99.86%

5Y return CAGR

-73.07%

5Y total return

-99.86%

6M price change

-85.5%

6M total return

-85.5%

All-time high

$360.25

All-time high date

2020-12-11

All-time low

$0.12

All-time low date

2026-10-28

Average true range (ATR)

$0.01

Average volume

8.2M

Beta (1Y)

-1.12

Beta (2Y)

0.47

Beta (5Y)

6.07

Change from 52-week high

-95.72%

Change from 52-week low

4.23%

Change from all-time high

-99.97%

Change from all-time low

5.79%

Change from open

1.31%

Day's gap

-5.14%

Dollar volume

$100,219

High price

$0.12

Low price

$0.12

Monthly RSI

35.97

Open price

$0.12

Position in 52-week range

94.29%

Premarket change

-4.36%

Premarket close

$0.13

Premarket price

$0.12

Premarket volume

24.1K

Previous close

$0.13

Price vs 150-day SMA

-75.05%

Price vs 20-day SMA

-10.99%

Price vs 200-day SMA

-83.58%

Price vs 50-day SMA

-27.11%

Relative volume

0.1

Return from IPO open

-99.93%

Return from IPO price

-97.86%

RSI

32.31

Sharpe ratio

-2.78

Sharpe ratio (3Y)

0.26

Sharpe ratio (5Y)

0.17

Sortino ratio

-3.46

Sortino ratio (3Y)

1.65

Sortino ratio (5Y)

0.9

Volume

812.8K

Weekly RSI

23.54

YTD price change

-93.83%

YTD total return

-93.83%

Metric	Value
Float	19.1M
Float percentage	94.92%
Shares change (QoQ)	20.83%
Shares change (YoY)	72.97%
Shares held by insiders	5.08%
Shares held by institutions	16.05%
Shares outstanding	20.1M
Short % of float	15%
Short % of shares	14.24%
Short ratio	0.1 days

Metric

Value

Float

19.1M

Float percentage

94.92%

Shares change (QoQ)

20.83%

Shares change (YoY)

72.97%

Shares held by insiders

5.08%

Shares held by institutions

16.05%

Shares outstanding

20.1M

Short % of float

15%

Short % of shares

14.24%

Short ratio

0.1 days

Vivos Therapeutics, Inc. (VVOS)

Price

Financial snapshot

Fair-value bridge

Latest news · VVOS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VVOS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VVOS

Frequently asked questions